However, the ratio of IFN-γ+:IL-4+ B cells, a pro-inflammatory measure, which may represent the balance between Th1 (IFN-γ+) and Th2 (IL-4+) phenotypes,27 was significantly lower in melanoma patients compared to matched HV (Figure 2(c)). This evidence concerns the gene IFNG and melanoma.